Literature DB >> 5489771

The covalent structure of a human gamma G-immunoglobulin. VII. Amino acid sequence of heavy-chain cyanogen bromide fragments H1-H4.

B A Cunningham, U Rutishauser, W E Gall, P D Gottlieb, M J Waxdal, G M Edelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5489771     DOI： 10.1021/bi00818a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

1.  Cascade chromatography and automated multidimensional fractionation.

Authors:  G M Edelman; W E Gall
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

2.  Rearranged immunoglobulin heavy chain variable region (VH) pseudogene that deletes the second complementarity-determining region.

Authors:  N Takahashi; T Noma; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 3.  Genetic determination of antibody specificity. Gene translocation and fusion, the molecular basis for the differentiation of the antibody-producing cell.

Authors:  N Hilschmann; H U Barnikol; H Kratzin; P Altevogt; M Engelhard; S Barnikol-Watanabe
Journal:  Naturwissenschaften       Date:  1978-12

4.  Origins of immunoglobulin heavy chain domains.

Authors:  W C Barker; L K Ketcham; M O Dayhoff
Journal:  J Mol Evol       Date:  1980-05       Impact factor: 2.395

5.  cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain.

Authors:  C Auffray; A J Korman; M Roux-Dosseto; R Bono; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Complete amino acid sequences of variable regions of two human IgM rheumatoid factors, BOR and KAS of the Wa idiotypic family, reveal restricted use of heavy and light chain variable and joining region gene segments.

Authors:  M M Newkirk; R A Mageed; R Jefferis; P P Chen; J D Capra
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.